Astria Therapeutics Inc (ATXS)

Finanzdaten der Astria Therapeutics Inc-Aktie (ATXS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	29.38% 24.15	34.20	20.24	15.10	13.49
Operating Income/Loss	29.38% -24.15	-34.20	-20.24	-15.10	-13.49
Nonoperating Income/Loss	51.38% 4.222	2.789	2.509	2.536	2.305
Income/Loss From Continuing Operations Before Tax	36.56% -19.93	-31.41	-17.73	-12.57	-11.19
Income/Loss From Continuing Operations After Tax	36.56% -19.93	-31.41	-17.73	-12.57	-11.19
Net Income/Loss	36.56% -19.93	-31.41	-17.73	-12.57	-11.19
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,366% 52.29	2.1207	28.04	28.02	27.94
Diluted Average Shares	2,366% 52.29	2.1207	28.04	28.02	27.94
Basic Earnings Per Share	59.57% -0.38	-0.94	-0.63	-0.45	-0.40
Diluted Earnings Per Share	59.57% -0.38	-0.94	-0.63	-0.45	-0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-